Regulation of Renal Electrolyte Transport by WNK and SPAK-OSR1 Kinases

Annual Review of Physiology

Volumn 78, Issue , 2016, Pages 367-389

  Hadchouel, Juliette ^a,b   Ellison, David H ^c   Gamba, Gerardo ^d  

^a PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Diuretics; ENaC; Hypertension; NCC; ROMK; Salt transport; SLC12

Indexed keywords

CHLORIDE; EPITHELIAL SODIUM CHANNEL; OXIDATIVE STRESS RESPONSE KINASE 1; POTASSIUM; PROTEIN KINASE WNK1; PROTEIN KINASE WNK4; PROTEIN SERINE THREONINE KINASE; SODIUM CHLORIDE COTRANSPORTER; STERILE 20 RELATED PROLINE ALANINE RICH KINASE; UNCLASSIFIED DRUG; ELECTROLYTE; SIGNAL PEPTIDE;

CHLORIDE TRANSPORT; ELECTROLYTE TRANSPORT; GENE CONTROL; INTRACELLULAR SIGNALING; ION TRANSPORT; KIDNEY TUBULE CELL; NONHUMAN; OSMOLARITY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; ANIMAL; HUMAN; HYPERTENSION; KIDNEY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PSEUDOHYPOALDOSTERONISM;

ANIMALS; ELECTROLYTES; HUMANS; HYPERTENSION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ION TRANSPORT; KIDNEY; PROTEIN-SERINE-THREONINE KINASES; PSEUDOHYPOALDOSTERONISM;

EID: 84958664940     PISSN: 00664278     EISSN: 15451585     Source Type: Book Series    
DOI: 10.1146/annurev-physiol-021115-105431     Document Type: Review

References (131)

1. Narayan KM, Ali MK, Koplan JP. 2010. Global noncommunicable diseases-where worlds meet. N. Engl. J. Med. 363:1196-98
2. MayanH, Vered I, MouallemM, Tzadok-WitkonM, Pauzner R, Farfel Z. 2002. Pseudohypoaldosteronism type II: marked sensitivity to thiazides, hypercalciuria, normomagnesemia, and low bone mineral density. J. Clin. Endocrinol. Metab. 87:3248-54
3. Boyden LM, Choi M, Choate KA, Nelson-Williams CJ, Farhi A, et al. 2012. Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities. Nature 482:98-102
4. Louis-Dit-Picard H, Barc J, Trujillano D, Miserey-Lenkei S, Bouatia-Naji N, et al. 2012. KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephron. Nat. Genet. 44:456-60
5. Ohta A, Schumacher FR,Mehellou Y, Johnson C, Knebel A, et al. 2013. The CUL3-KLHL3 E3 ligase complex mutated in Gordon's hypertension syndrome interacts with and ubiquitylates WNK isoforms: Disease-causing mutations in KLHL3 andWNK4 disrupt interaction. Biochem. J. 451:111-22
6. McCormick JA, Yang CL, Zhang C, Davidge B, Blankenstein KI, et al. 2014. Hyperkalemic hypertension-associated cullin 3 promotes WNK signaling by degrading KLHL3. J. Clin. Investig. 124:4723-36
7. Lifton RP, Gharavi AG, Geller DS. 2001. Molecular mechanisms of human hypertension. Cell 104:545-56
8. Vidal-Petiot E, Elvira-Matelot E, MutigK, SoukaseumC, Baudrie V, et al. 2013. WNK1-related familial hyperkalemic hypertension results from an increased expression of L-WNK1 specifically in the distal nephron. PNAS 110:14366-71
9. Piechotta K, Lu J, Delpire E. 2002. Cation chloride cotransporters interact with the stress-related kinases Ste20-related proline-alanine-rich kinase (SPAK) and oxidative stress response 1 (OSR1). J. Biol. Chem. 277:50812-19
10. Gamba G. 2005. Molecular physiology and pathophysiology of the electroneutral cation-chloride cotransporters. Physiol. Rev. 85:423-93
11. Gagnon KB, Delpire E. 2012. Molecular physiology of SPAK and OSR1: two Ste20-related protein kinases regulating ion transport. Physiol. Rev. 92:1577-617
12. Gagnon KB, England R, Delpire E. 2006. Characterization of SPAK and OSR1, regulatory kinases of the Na-K-2Cl cotransporter. Mol. Cell. Biol. 26:689-98
13. Johnston AM, Naselli G, Gonez LJ, Martin RM, Harrison LC, DeAizpurua HJ. 2000. SPAK, a STE20/SPS1-related kinase that activates the p38 pathway. Oncogene 19:4290-97
14. Tamari M, Daigo Y,Nakamura Y. 1999. Isolation and characterization of a novel serine threonine kinase gene on chromosome 3p22-21.3. J. Hum. Genet. 44:116-20
15. Piechotta K, Garbarini N, England R, Delpire E. 2003. Characterization of the interaction of the stress kinase SPAK with the Na+-K+-2Cl-cotransporter in the nervous system: evidence for a scaffolding role of the kinase. J. Biol. Chem. 278:52848-56
16. Rafiqi FH, Zuber AM, Glover M, Richardson C, Fleming S, et al. 2010. Role of the WNK-activated SPAK kinase in regulating blood pressure. EMBO Mol. Med. 2:63-75
17. McCormick JA, MutigK,Nelson JH, SaritasT,Hoorn EJ, et al. 2011. A SPAK isoform switch modulates renal salt transport and blood pressure. Cell Metab. 14:352-64
18. Saritas T, Borschewski A, McCormick JA, Paliege A, Dathe C, et al. 2013. SPAK differentially mediates vasopressin effects on sodium cotransporters. J. Am. Soc. Nephrol. 24:407-18
19. Markadieu N, Rios K, Spiller BW, McDonald WH, Welling PA, Delpire E. 2014. Short forms of Ste20-related proline/alanine-rich kinase (SPAK) in the kidney are created by aspartyl aminopeptidase (Dnpep)-mediated proteolytic cleavage. J. Biol. Chem. 289:29273-84
20. Chen W, Yazicioglu M, Cobb MH. 2004. Characterization of OSR1, a member of the mammalian Ste20p/germinal center kinase subfamily. J. Biol. Chem. 279:11129-36
21. Grimm PR, Taneja TK, Liu J, Coleman R, Chen YY, et al. 2012. SPAK isoforms and OSR1 regulate sodium-chloride co-transporters in a nephron-specific manner. J. Biol. Chem. 287:37673-90
22. Moriguchi T, Urushiyama S, Hisamoto N, Iemura S, Uchida S, et al. 2005. WNK1 regulates phosphorylation of cation-chloride-coupled cotransporters via the STE20-related kinases, SPAK and OSR1. J. Biol. Chem. 280:42685-93
23. Gagnon KB, England R, Delpire E. 2006. Volume sensitivity of cation-Cl-cotransporters is modulated by the interaction of two kinases: Ste20-related proline-alanine-rich kinase andWNK4. Am. J. Physiol. Cell Physiol. 290:C134-42
24. Vitari AC, Deak M, Morrice NA, Alessi DR. 2005. The WNK1 and WNK4 protein kinases that are mutated in Gordon's hypertension syndrome, phosphorylate and activate SPAK and OSR1 protein kinases. Biochem. J. 391:17-24
25. Richardson C, Alessi DR. 2008. The regulation of salt transport and blood pressure by the WNKSPAK/ OSR1 signalling pathway. J. Cell Sci. 121:3293-304
26. Verissimo F, Jordan P. 2001.WNKkinases, a novel protein kinase subfamily in multi-cellular organisms. Oncogene 20:5562-69
27. XuB, English JM, Wilsbacher JL, Stippec S,Goldsmith EJ, CobbMH.2000.WNK1,a novel mammalian serine/threonine protein kinase lacking the catalytic lysine in subdomain II. J. Biol. Chem. 275:16795-801
28. Chavez-CanalesM, Zhang C, Soukaseum C,Moreno E, Pacheco-Alvarez D, et al. 2014. WNK-SPAKNCC cascade revisited: WNK1 stimulates the activity of the Na-Cl cotransporter via SPAK, an effect antagonized byWNK4. Hypertension 64:1047-53
29. Thastrup JO, Rafiqi FH, Vitari AC, Pozo-Guisado E, Deak M, et al. 2012. SPAK/OSR1 regulate NKCC1 and WNK activity: analysis of WNK isoform interactions and activation by T-loop transautophosphorylation. Biochem. J. 441:325-37
30. Delaloy C, Lu J,Houot AM,Disse-Nicodeme S, Gasc JM, et al. 2003. Multiple promoters in theWNK1 gene: One controls expression of a kidney-specific kinase-defective isoform. Mol. Cell. Biol. 23:9208-21
31. O'Reilly M, Marshall E, Speirs HJ, Brown RW. 2003. WNK1, a gene within a novel blood pressure control pathway, tissue-specifically generates radically different isoforms with and without a kinase domain. J. Am. Soc. Nephrol. 14:2447-56
32. Vidal-Petiot E, Cheval L, Faugeroux J, Malard T, Doucet A, et al. 2012. A new methodology for quantification of alternatively spliced exons reveals a highly tissue-specific expression pattern of WNK1 isoforms. PLOS ONE 7:e37751
33. Shekarabi M, Girard N, Riviere JB, Dion P, Houle M, et al. 2008. Mutations in the nervous systemspecific HSN2 exon ofWNK1 cause hereditary sensory neuropathy type II. J. Clin. Investig. 118:2496-505
34. Wilson FH, Disse-Nicodeme S, Choate KA, Ishikawa K, Nelson-Williams C, et al. 2001. Human hypertension caused by mutations in WNK kinases. Science 293:1107-12
35. Holden S, Cox J, Raymond FL. 2004. Cloning, genomic organization, alternative splicing and expression analysis of the human gene WNK3 (PRKWNK3). Gene 335:109-19
36. Kahle KT,Rinehart J,DeLos Heros P,LouviA,Meade P, et al. 2005.WNK3modulates transport ofCl-in and out of cells: implications for control of cell volume and neuronal excitability. PNAS 102:16783-88
37. Oi K, Sohara E, Rai T, Misawa M, Chiga M, et al. 2012. A minor role of WNK3 in regulating phosphorylation of renal NKCC2 and NCC co-transporters in vivo. Biol. Open 1:120-27
38. O'Reilly M, Marshall E, Macgillivray T, Mittal M, Xue W, et al. 2006. Dietary electrolyte-driven responses in the renalWNK kinase pathway in vivo. J. Am. Soc. Nephrol. 17:2402-13
39. Ohno M, Uchida K, Ohashi T, Nitta K, Ohta A, et al. 2011. Immunolocalization of WNK4 in mouse kidney. Histochem. Cell Biol. 136:25-35
40. Richardson C, Rafiqi FH, Karlsson HK, Moleleki N, Vandewalle A, et al. 2008. Activation of the thiazide-sensitive Na+-Cl-cotransporter by the WNK-regulated kinases SPAK and OSR1. J. Cell Sci. 121:675-84
41. Yang SS, Lo YF, Wu CC, Lin SW, Yeh CJ, et al. 2010. SPAK-knockout mice manifest Gitelman syndrome and impaired vasoconstriction. J. Am. Soc. Nephrol. 21:1868-77
42. Grimm PR, Lazo-Fernandez Y, Delpire E,Wall SM, Dorsey SG, et al. 2015. Integrated compensatory network is activated in the absence of NCC phosphorylation. J. Clin. Investig. 125:2136-50
43. Loffing J, Vallon V, Loffing-Cueni D, Aregger F, Richter K, et al. 2004. Altered renal distal tubule structure and renal Na+ and Ca2+ handling in a mouse model for Gitelman's syndrome. J. Am. Soc. Nephrol. 15:2276-88
44. Lin SH, Yu IS, Jiang ST, Lin SW, Chu P, et al. 2011. Impaired phosphorylation of Na+-K+-2Cl-cotransporter by oxidative stress-responsive kinase-1 deficiency manifests hypotension and Bartter-like syndrome. PNAS 108:17538-43
45. Xie J, Yoon J, Yang SS, Lin SH, Huang CL. 2013. WNK1 protein kinase regulates embryonic cardiovascular development through the OSR1 signaling cascade. J. Biol. Chem. 288:8566-74
46. Yang CL, Zhu X, Wang Z, Subramanya AR, Ellison DH. 2005. Mechanisms of WNK1 and WNK4 interaction in the regulation of thiazide-sensitive NaCl cotransport. J. Clin. Investig. 115:1379-87
47. Ellison DH. 2003. The thiazide-sensitive Na-Cl cotransporter and human disease: reemergence of an old player. J. Am. Soc. Nephrol. 14:538-40
48. Xie J,Wu T, Xu K, Huang IK, Cleaver O, Huang CL. 2009. Endothelial-specific expression of WNK1 kinase is essential for angiogenesis and heart development in mice. Am. J. Pathol. 175:1315-27
49. Zambrowicz BP, Abuin A, Ramirez-Solis R, Richter LJ, Piggott J, et al. 2003. Wnk1 kinase deficiency lowers blood pressure in mice: a gene-trap screen to identify potential targets for therapeutic intervention. PNAS 100:14109-14
50. Pacheco-Alvarez D, Vazquez N, Castaneda-Bueno M, de los Heros P, Cortes-Gonzalez C, et al. 2012. WNK3-SPAK interaction is required for the modulation of NCC and other members of the SLC12 family. Cell. Physiol. Biochem. 29:291-302
51. Rinehart J, Kahle KT, De Los Heros P, Vazquez N, Meade P, et al. 2005. WNK3 kinase is a positive regulator of NKCC2 and NCC, renal cation-Cl-cotransporters required for normal blood pressure homeostasis. PNAS 102:16777-82
52. Glover M, Zuber AM, O'Shaughnessy KM. 2009. Renal and brain isoforms of WNK3 have opposite effects on NCCT expression. J. Am. Soc. Nephrol. 20:1314-22
53. Cruz-Rangel S, Melo Z, Vazquez N, Meade P, Bobadilla NA, et al. 2011. Similar effects of all WNK3 variants on SLC12 cotransporters. Am. J. Physiol. Cell Physiol. 301:C601-08
54. Mederle K, Mutig K, Paliege A, Carota I, Bachmann S, et al. 2013. Loss of WNK3 is compensated for by theWNK1/SPAK axis in the kidney of the mouse. Am. J. Physiol. Ren. Physiol. 304:F1198-209
55. Bazua-Valenti S, Gamba G. 2015. Revisiting the NaCl cotransporter regulation by with-no-lysine kinases. Am. J. Physiol. Cell Physiol. 308:C779-91
56. Gamba G. 2012. Regulation of the renal Na+:Cl-cotransporter by phosphorylation and ubiquitylation. Am. J. Physiol. Ren. Physiol. 303:F1573-83
57. San Cristobal P, Pacheco-Alvarez D, Richardson C, Ring AM, Vazquez N, et al. 2009. Angiotensin II signaling increases activity of the renal Na-Cl cotransporter through a WNK4-SPAK-dependent pathway. PNAS 106:4384-89
58. Castaneda-Bueno M, Cervantes-Perez LG, VazquezN, Uribe N, Kantesaria S, et al. 2012. Activation of the renal Na+:Cl-cotransporter by angiotensin II is aWNK4-dependent process. PNAS 109:7929-34
59. Rozansky DJ, Cornwall T, Subramanya AR, Rogers S, Yang YF, et al. 2009. Aldosterone mediates activation of the thiazide-sensitiveNa-Cl cotransporter through an SGK1andWNK4signaling pathway. J. Clin. Investig. 119:2601-12
60. Ponce-Coria J, San Cristobal P, Kahle KT, Vazquez N, Pacheco-Alvarez D, et al. 2008. Regulation of NKCC2 by a chloride-sensing mechanism involving the WNK3 and SPAK kinases. PNAS 105:8458-63
61. Yang CL, Zhu X, Ellison DH. 2007. The thiazide-sensitiveNa-Cl cotransporter is regulated by aWNK kinase signaling complex. J. Clin. Investig. 117:3403-11
62. Bazua-Valenti S, Chavez-Canales M, Rojas-Vega L, Gonzalez-Rodriguez X, Vazquez N, et al. 2015. The effect ofWNK4 on the Na+-Cl-cotransporter is modulated by intracellular chloride. J. Am. Soc. Nephrol. 26:1781-86
63. Rinehart J, Vazquez N, Kahle KT, Hodson CA, Ring AM, et al. 2011. WNK2 is a novel regulator of essential neuronal cation-chloride cotransporters. J. Biol. Chem. 286:30171-80
64. Pacheco-Alvarez D, San Cristobal P, Meade P, Moreno E, Vazquez N, et al. 2006. The Na-Cl cotransporter is activated and phosphorylated at the amino terminal domain upon intracellular chloride depletion. J. Biol. Chem. 281:28755-63
65. Dowd BF, Forbush B. 2003. PASK (proline-alanine-rich STE20-related kinase), a regulatory kinase of the Na-K-Cl cotransporter (NKCC1). J. Biol. Chem. 278:27347-53
66. Lytle C, Forbush B III. 1996. Regulatory phosphorylation of the secretory Na-K-Cl cotransporter: modulation by cytoplasmic Cl. Am. J. Physiol. 270:C437-48
67. Gamba G. 2005. WNK lies upstream of kinases involved in regulation of ion transporters. Biochem. J. 391:e1-3
68. Pacheco-Alvarez D, Gamba G. 2011. WNK3 is a putative chloride-sensing kinase. Cell. Physiol. Biochem. 28:1123-34
69. Piala AT, Moon TM, Akella R, He H, Cobb MH, Goldsmith EJ. 2014. Chloride sensing by WNK1 involves inhibition of autophosphorylation. Sci. Signal. 7:ra41
70. Terker AS, Zhang C, Erspamer KJ, Gamba G, Yang CL, Ellison DH. 2015. Unique chloride-sensing properties ofWNK4 permit the distal nephron to modulate potassium homeostasis. Kidney Int. In press. doi: 10.1038/ki.2015.289
71. Castaneda-Bueno M, Cervantes-Perez LG, Rojas-Vega L, Arroyo-Garza I, Vazquez N, et al. 2014. Modulation of NCC activity by low and high K+ intake: insights into the signaling pathways involved. Am. J. Physiol. Ren. Physiol. 306:F1507-19
72. Vallon V, Schroth J, Lang F, Kuhl D, Uchida S. 2009. Expression and phosphorylation of the Na-Clcotransporter NCC in vivo is regulated by dietary salt, potassium and SGK1. Am. J. Physiol. Ren. Physiol. 297:F704-12
73. Sorensen MV,Grossmann S, RoesingerM,GreskoN, Todkar AP, et al. 2013. Rapid dephosphorylation of the renal sodium chloride cotransporter in response to oral potassium intake in mice. Kidney Int. 83:811-24
74. Nguyen MT, Yang LE, Fletcher NK, Lee DH,KocinskyH, et al. 2012. Effects ofK+-deficient dietswith and without NaCl supplementation on Na+, K+, andH2O transporters' abundance along the nephron. Am. J. Physiol. Ren. Physiol. 303:F92-104
75. Arroyo JP, RonzaudC, LagnazD, Staub O, GambaG. 2011. Aldosterone paradox: differential regulation of ion transport in distal nephron. Physiology 26:115-23
76. Lalioti MD, Zhang J, Volkman HM, Kahle KT, Hoffmann KE, et al. 2006. WNK4 controls blood pressure and potassium homeostasis via regulation of mass and activity of the distal convoluted tubule. Nat. Genet. 38:1124-32
77. Wade JB, Liu J, Coleman R,Grimm PR,Delpire E, Welling PA. 2015. SPAK-mediatedNCCregulation in response to low-K+ diet. Am. J. Physiol. Ren. Physiol. 308:F923-31
78. Terker AS, Zhang C,McCormick JA, Lazelle RA, Zhang C, et al. 2015. Potassium modulates electrolyte balance and blood pressure through effects on distal cell voltage and chloride. Cell Metab. 21:39-50
79. Moes AD, van der Lubbe N, Zietse R, Loffing J, Hoorn EJ. 2014. The sodium chloride cotransporter SLC12A3: new roles in sodium, potassium, and blood pressure regulation. Pflugers Arch. 466:107-18
80. Scholl UI, Choi M, Liu T, Ramaekers VT, Hausler MG, et al. 2009. Seizures, sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance (SeSAME syndrome) caused by mutations in KCNJ10. PNAS 106:5842-47
81. Zhang C, Wang L, Zhang J, Su XT, Lin DH, et al. 2014. KCNJ10 determines the expression of the apical Na-Cl cotransporter (NCC) in the early distal convoluted tubule (DCT1). PNAS 111:11864-69
82. Cope G, Murthy M, Golbang AP, Hamad A, Liu CH, et al. 2006. WNK1 affects surface expression of the ROMK potassium channel independent of WNK4. J. Am. Soc. Nephrol. 17:1867-74
83. Lazrak A, LiuZ,Huang CL. 2006. Antagonistic regulation ofROMKby long and kidney-specificWNK1 isoforms. PNAS 103:1615-20
84. He G, Wang HR, Huang SK, Huang CL. 2007. Intersectin links WNK kinases to endocytosis of ROMK1. J. Clin. Investig. 117:1078-87
85. Fang L, Garuti R, Kim BY,Wade JB, Welling PA. 2009. The ARHadaptor protein regulates endocytosis of the ROMK potassium secretory channel in mouse kidney. J. Clin. Investig. 119:3278-89
86. Wang HR, Liu Z, Huang CL. 2008. Domains of WNK1 kinase in the regulation of ROMK1. Am. J. Physiol. Ren. Physiol. 295:F438-45
87. Fang L, Welling PA. 2011. L-WNK1 stimulates ROMK endocytosis by phosphorylation-dependent stabilization of ARH. FASEB J. 25(Suppl.):1041.33
88. Wade JB, Fang L, Liu J, Li D, Yang CL, et al. 2006. WNK1 kinase isoform switch regulates renal potassium excretion. PNAS 103:8558-63
89. Liu Z, Wang HR, Huang CL. 2009. Regulation of ROMK channel and K+ homeostasis by kidneyspecificWNK1 kinase. J. Biol. Chem. 284:12198-206
90. Cheng CJ, Baum M, Huang CL. 2013. Kidney-specific WNK1 regulates sodium reabsorption and potassium secretion in mouse cortical collecting duct. Am. J. Physiol. Ren. Physiol. 304:F397-402
91. Hadchouel J, Soukaseum C, Busst C, Zhou XO, Baudrie V, et al. 2010. Decreased ENaC expression compensates the increasedNCC activity following inactivation of the kidney-specific isoform of WNK1 and prevents hypertension. PNAS 107:18109-14
92. Kahle KT,Wilson FH, Leng Q, Lalioti MD, O'Connell AD, et al. 2003. WNK4 regulates the balance between renal NaCl reabsorption and K+ secretion. Nat. Genet. 35:372-76
93. Ring AM, Leng Q, Rinehart J, Wilson FH, Kahle KT, et al. 2007. An SGK1 site in WNK4 regulates Na+ channel andK+ channel activity and has implications for aldosterone signaling andK+ homeostasis. PNAS 104:4025-29
94. Yue P, Lin DH, Pan CY, Leng Q, Giebisch G, et al. 2009. Src family protein tyrosine kinase (PTK) modulates the effect of SGK1 and WNK4 on ROMK channels. PNAS 106:15061-66
95. LinDH, Yue P, YarboroughO3rd, Scholl UI, Giebisch G, et al. 2015. Src-family protein tyrosine kinase phosphorylates WNK4 and modulates its inhibitory effect on KCNJ1 (ROMK). PNAS 112:4495-500
96. Liu Y, Song X, Shi Y, Shi Z, NiuW, et al. 2015. WNK1 activates large-conductance Ca2+-activated K+ channels through modulation of ERK1/2 signaling. J. Am. Soc. Nephrol. 26:844-54
97. Zhuang J, Zhang X,Wang D, Li J, Zhou B, et al. 2011. WNK4 kinase inhibits Maxi K channel activity by a kinase-dependent mechanism. Am. J. Physiol. Ren. Physiol. 301:F410-19
98. Wang Z, Subramanya AR, Satlin LM, Pastor-Soler NM, Carattino MD, Kleyman TR. 2013. Regulation of large-conductance Ca2+-activated K+ channels by WNK4 kinase. Am. J. Physiol. Cell Physiol. 305:C846-53
99. Yue P, Zhang C, Lin DH, Sun P, Wang WH. 2013. WNK4 inhibits Ca2+-activated big-conductance potassium channels (BK) viamitogen-activated protein kinase-dependent pathway. Biochim. Biophys. Acta 1833:2101-10
100. Ring AM, Cheng SX, Leng Q, Kahle KT, Rinehart J, et al. 2007. WNK4 regulates activity of the epithelial Na+ channel in vitro and in vivo. PNAS 104:4020-24
101. Yu L, Cai H, Yue Q, Alli AA, Wang D, et al. 2013. WNK4 inhibition of ENaC is independent of Nedd4-2-mediated ENaC ubiquitination. Am. J. Physiol. Ren. Physiol. 305:F31-41
102. Yang SS, Morimoto T, Rai T, Chiga M, Sohara E, et al. 2007. Molecular pathogenesis of pseudohypoaldosteronism type II: generation and analysis of a Wnk4D561A/+ knockin mouse model. Cell Metab. 5:331-44
103. Xu BE, Stippec S, Chu PY, Lazrak A, Li XJ, et al. 2005. WNK1 activates SGK1 to regulate the epithelial sodium channel. PNAS 102:10315-20
104. Heise CJ, Xu BE, Deaton SL, Cha SK, Cheng CJ, et al. 2010. Serum and glucocorticoid-induced kinase (SGK) 1 and the epithelial sodium channel are regulated by multiple with no lysine (WNK) family members. J. Biol. Chem. 285:25161-67
105. Yang CL, Liu X, Paliege A, Zhu X, Bachmann S, et al. 2007. WNK1 and WNK4 modulate CFTR activity. Biochem. Biophys. Res. Commun. 353:535-40
106. Kahle KT, Gimenez I, Hassan H, Wilson FH, Wong RD, et al. 2004. WNK4 regulates apical and basolateral Cl-flux in extrarenal epithelia. PNAS 101:2064-69
107. Ohta A, Yang SS, Rai T, Chiga M, Sasaki S, Uchida S. 2006. Overexpression of humanWNK1 increases paracellular chloride permeability and phosphorylation of claudin-4 in MDCKII cells. Biochem. Biophys. Res. Commun. 349:804-8
108. Yamauchi K, Rai T, Kobayashi K, Sohara E, Suzuki T, et al. 2004. Disease-causing mutant WNK4 increases paracellular chloride permeability and phosphorylates claudins. PNAS 101:4690-94
109. Tatum R, Zhang Y, Lu Q, Kim K, Jeansonne BG, Chen YH. 2007. WNK4 phosphorylates ser206 of claudin-7 and promotes paracellular Cl-permeability. FEBS Lett. 581:3887-91
110. Yang SS, Hsu YJ, Chiga M, Rai T, Sasaki S, et al. 2010. Mechanisms for hypercalciuria in pseudohypoaldosteronism type II-causing WNK4 knock-in mice. Endocrinology 151:1829-36
111. Jiang Y, Cong P,Williams SR, ZhangW, Na T, et al. 2008. WNK4 regulates the secretory pathway via which TRPV5 is targeted to the plasma membrane. Biochem. Biophys. Res. Commun. 375:225-29
112. Jiang Y, FergusonWB, Peng JB. 2007. WNK4 enhances TRPV5-mediated calcium transport: potential role in hypercalciuria of familial hyperkalemic hypertension caused by gene mutation of WNK4. Am. J. Physiol. Ren. Physiol. 292:F545-54
113. Cha SK, HuangCL. 2010.WNK4kinase stimulates caveola-mediated endocytosis of TRPV5 amplifying the dynamic range of regulation of the channel by protein kinase C. J. Biol. Chem. 285:6604-11
114. Andrukhova O, Smorodchenko A, Egerbacher M, Streicher C, Zeitz U, et al. 2014. FGF23 promotes renal calcium reabsorption through the TRPV5 channel. EMBO J. 33:229-46
115. Alessi DR, Zhang J, Khanna A, Hochdorfer T, Shang Y, Kahle KT. 2014. The WNK-SPAK/OSR1 pathway: master regulator of cation-chloride cotransporters. Sci. Signal. 7:re3
116. Cohen P, Alessi DR. 2013. Kinase drug discovery-what's next in the field? ACS Chem. Biol. 8:96-104
117. Kikuchi E, Mori T, ZeniyaM,Isobe K, Ishigami-YuasaM, et al. 2015. Discovery of novelSPAKinhibitors that blockWNK kinase signaling to cation chloride transporters. J. Am. Soc. Nephrol. 26:1525-36
118. Wakabayashi M, Mori T, Isobe K, Sohara E, Susa K, et al. 2013. Impaired KLHL3-mediated ubiquitination of WNK4 causes human hypertension. Cell Rep. 3:858-68
119. Wu G, Peng JB. 2013. Disease-causing mutations in KLHL3 impair its effect on WNK4 degradation. FEBS Lett. 587:1717-22
120. Na T,WuG, ZhangW,DongWJ, Peng JB. 2013. Disease-causing R1185C mutation ofWNK4disrupts a regulatory mechanism involving calmodulin binding and SGK1 phosphorylation sites. Am. J. Physiol. Ren. Physiol. 304:F8-18
121. Shibata S, Zhang J, Puthumana J, Stone KL, Lifton RP. 2013. Kelch-like 3 and Cullin 3 regulate electrolyte homeostasis via ubiquitination and degradation of WNK4. PNAS 110:7838-43
122. Liu Z, Xie J, Wu T, Truong T, Auchus RJ, Huang CL. 2011. Downregulation of NCC and NKCC2 cotransporters by kidney-specific WNK1 revealed by gene disruption and transgenic mouse models. Hum. Mol. Genet. 20:855-66
123. Ohta A, Rai T, Yui N, Chiga M, Yang SS, et al. 2009. Targeted disruption of the Wnk4 gene decreases phosphorylation of Na-Cl cotransporter, increases Na excretion, and lowers blood pressure. Hum. Mol. Genet. 18:3978-86
124. Takahashi D,Mori T, Nomura N, KhanMZ, Araki Y, et al. 2014. WNK4 is the majorWNKpositively regulating NCC in the mouse kidney. Biosci. Rep. 34:e00107
125. Deleted in proof
126. Cheng CJ, Yoon J, Baum M, Huang CL. 2015. STE20/SPS1-related proline/alanine-rich kinase (SPAK) is critical for sodium reabsorption in isolated, perfused thick ascending limb. Am. J. Physiol. Ren. Physiol. 308:F437-43
127. ChigaM, Rafiqi FH, Alessi DR, Sohara E, Ohta A, et al. 2011. Phenotypes of pseudohypoaldosteronism type II caused by the WNK4 D561A missense mutation are dependent on the WNK-OSR1/SPAK kinase cascade. J. Cell Sci. 124:1391-95
128. Susa K, Kita S, Iwamoto T, Yang SS, Lin SH, et al. 2012. Effect of heterozygous deletion of WNK1 on theWNK-OSR1/ SPAK-NCC/NKCC1/NKCC2 signal cascade in the kidney and blood vessels. Clin. Exp. Nephrol. 16:530-38
129. Chu PY, Cheng CJ, Wu YC, Fang YW, Chau T, et al. 2013. SPAK deficiency corrects pseudohypoaldosteronism II caused byWNK4 mutation. PLOS ONE 8:e72969
130. Weinstein AM. 2005. A mathematical model of rat distal convoluted tubule. I. Cotransporter function in early DCT. Am. J. Physiol. Ren. Physiol. 289:F699-720
131. Boettger T, Hubner CA, Maier H, Rust MB, Beck FX, Jentsch TJ. 2002. Deafness and renal tubular acidosis in mice lacking the K-Cl co-transporter Kcc4. Nature 416:874-78